How much funding has EpiPaws raised?

EpiPaws has raised $250K in total funding, most recently a Seed round.

Who are EpiPaws's investors?

EpiPaws's investors include New World Angels, Kevin O'Leary.

Where is EpiPaws headquartered?

EpiPaws is headquartered in Topeka, Kansas, United States.

What industry is EpiPaws in?

EpiPaws operates in Animal Health, Biotech, Healthcare.

EpiPaws

Uncover how fast your pet is aging on the inside

Topeka, United States · $250K raised

Animal Health

Biotech

Healthcare

Headquarters: Topeka, Kansas
Employees: 1–10
Business Model: B2C
Website: epipaws.com

Total Funding: $250K
Last Round: $250K SeedJul 2025
Rounds: 3

About

EpiPaws is a pet health company offering epigenetic DNA testing kits that determine a pet's biological age and health insights. Its flagship HealthScore Test for Dogs analyzes DNA biomarkers via a simple cheek swab to estimate chronological age, establish a health baseline, and track aging over time. The company also offers cat age tests and conducts epigenetic research in collaboration with veterinarians and shelters. Founded by Andria Beal, PhD, EpiPaws targets pet owners, veterinarians, shelters, and rescues, providing science-backed actionable insights for proactive pet healthcare. The platform is powered by Shopify and ships internationally.

Summary

EpiPaws is an Animal Health company based in Topeka, United States. It has raised $250K in total across 3 rounds, most recently a $250K Seed round in Jul 2025. Investors include New World Angels and Kevin O'Leary.